Initial experience and results of a single-branched TEVAR system in Scandinavia.

Samuel Saers, Reshaabi Srinanthalogen, Tomas Ohrlander, Sofia Strömberg, Timothy A Resch, Jacob Budtz-Lilly, Robert C Lind
{"title":"Initial experience and results of a single-branched TEVAR system in Scandinavia.","authors":"Samuel Saers, Reshaabi Srinanthalogen, Tomas Ohrlander, Sofia Strömberg, Timothy A Resch, Jacob Budtz-Lilly, Robert C Lind","doi":"10.23736/S0021-9509.25.13330-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thoracic endovascular aortic repair (TEVAR) often requires landing in zone 1 or 2 thereby compromising flow through the supra-aortic branch vessels. The Castor (Microport Medical, Shanghai, China) single branched TEVAR system has an incorporated side branch allowing treatment of pathologies reaching zone 2 and 3, whilst preserving flow to aortic arch side branches. This study aims to report on the initial experience and short-term results of all Castor cases done in Scandinavia.</p><p><strong>Methods: </strong>All patients treated with a Castor stent graft in Scandinavia were included in this study. Pre- and postoperative radiologic imaging were examined. Medical journals were investigated. Operative data, technical success, survival, major adverse events and reinterventions were recorded and analyzed retrospectively.</p><p><strong>Results: </strong>Twenty-three patients received a Castor in four different Scandinavian hospitals and were included in this study. Treated pathology included type B dissection (N.=10), penetrating aortic ulcer (N.=3), degenerative aortic aneurysm (N.=7), infective native aortic aneurysm (N.=1), Lusorian aneurysm (N.=1) and a proximal stent graft induced new entry after a previous TEVAR (N.=1). The Castor was deployed in zone 2 with side branch placement in the left subclavian artery (N.=16) or zone 1 with side branch placement in the left common carotid artery (N.=7). Technical success was achieved in 96% (N.=22). Median follow-up was 359 (147-664) days with a side branch patency of 95%. No major adverse events occurred within 30 days. Two reinterventions were performed during follow-up due to a distal stent graft induced new entry. One patient died from myocardial infarction 92 days after the Castor procedure.</p><p><strong>Conclusions: </strong>This multicenter retrospective study represents largest contemporary European series. Short-term results and initial experience were good with no peri-operative strokes, spinal cord ischemia or death reported.</p>","PeriodicalId":101333,"journal":{"name":"The Journal of cardiovascular surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of cardiovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0021-9509.25.13330-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thoracic endovascular aortic repair (TEVAR) often requires landing in zone 1 or 2 thereby compromising flow through the supra-aortic branch vessels. The Castor (Microport Medical, Shanghai, China) single branched TEVAR system has an incorporated side branch allowing treatment of pathologies reaching zone 2 and 3, whilst preserving flow to aortic arch side branches. This study aims to report on the initial experience and short-term results of all Castor cases done in Scandinavia.

Methods: All patients treated with a Castor stent graft in Scandinavia were included in this study. Pre- and postoperative radiologic imaging were examined. Medical journals were investigated. Operative data, technical success, survival, major adverse events and reinterventions were recorded and analyzed retrospectively.

Results: Twenty-three patients received a Castor in four different Scandinavian hospitals and were included in this study. Treated pathology included type B dissection (N.=10), penetrating aortic ulcer (N.=3), degenerative aortic aneurysm (N.=7), infective native aortic aneurysm (N.=1), Lusorian aneurysm (N.=1) and a proximal stent graft induced new entry after a previous TEVAR (N.=1). The Castor was deployed in zone 2 with side branch placement in the left subclavian artery (N.=16) or zone 1 with side branch placement in the left common carotid artery (N.=7). Technical success was achieved in 96% (N.=22). Median follow-up was 359 (147-664) days with a side branch patency of 95%. No major adverse events occurred within 30 days. Two reinterventions were performed during follow-up due to a distal stent graft induced new entry. One patient died from myocardial infarction 92 days after the Castor procedure.

Conclusions: This multicenter retrospective study represents largest contemporary European series. Short-term results and initial experience were good with no peri-operative strokes, spinal cord ischemia or death reported.

斯堪的纳维亚地区单分支TEVAR系统的初步经验和结果。
背景:胸主动脉血管内修复(TEVAR)通常需要在1区或2区着陆,从而影响主动脉上分支血管的血流。Castor (Microport Medical, Shanghai, China)单支TEVAR系统有一个合并的侧分支,允许治疗到达2区和3区的病变,同时保持主动脉弓侧分支的血流。本研究旨在报告在斯堪的纳维亚半岛所有蓖麻病例的初步经验和短期结果。方法:所有在斯堪的纳维亚接受Castor支架移植治疗的患者纳入本研究。检查术前和术后影像学。对医学期刊进行了调查。回顾性记录和分析手术资料、技术成功、生存、主要不良事件和再干预。结果:23名患者在四家不同的斯堪的纳维亚医院接受Castor治疗,并纳入本研究。治疗的病理包括B型夹层(10例)、穿透性主动脉溃疡(3例)、退行性主动脉瘤(7例)、感染性原生主动脉瘤(1例)、Lusorian动脉瘤(1例)和先前TEVAR术后近端支架移植诱导的新动脉瘤(1例)。Castor被放置在左侧锁骨下动脉侧支放置的2区(n =16)或左侧颈总动脉侧支放置的1区(n =7)。技术成功率96% (n =22)。中位随访时间为359(147-664)天,侧支通畅率为95%。30天内未发生重大不良事件。在随访期间,由于远端支架移植引起新的进入,进行了两次再干预。一名患者在Castor手术后92天死于心肌梗死。结论:这项多中心回顾性研究是当代欧洲最大的系列研究。短期结果和初步经验良好,无围手术期卒中、脊髓缺血或死亡报告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信